Have a personal or library account? Click to login

References

  1. 1. Beck S, Wojdyla D, Say L, Betrain AP, Merialdi M, Requejo JH. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization, 2010;88(1):31-8.10.2471/BLT.08.062554
  2. 2. Office for National Statistics. Child mortality in England and Wales: 2016. Stillbirths, infant and childhood deaths occurring annually in England and Wales, and associated risk factors. Statistical Buletin [Internet]. 2018 [cited 2019 Jan 04]. Available from: https://www.ons.gov.uk/.
  3. 3. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027-35.10.1016/S0140-6736(16)31593-8
  4. 4. Marlow N, Wolke D, Bracewell MA, Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005;352: 9-19.10.1056/NEJMoa041367
  5. 5. Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics. 2004;114(2):372-6.10.1542/peds.114.2.372
  6. 6. Huddy C, Johnson A, Hope P. Educational and behavioral problems in babies of 32-35 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001;85(1):F23-8.10.1136/fn.85.1.F23
  7. 7. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.10.1016/S0140-6736(08)60074-4
  8. 8. Barros FC, Papageorghiou AT, Victora CG, Noble JA, Pang R, Iams J et al. The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. JAMA Pediatr. 2015;169(3):220-9.10.1001/jamapediatrics.2014.304025561016
  9. 9. Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, et al. The phenotype of spontaneous preterm birth: application of a clinical phenotyping tool. Am J Obstet Gynecol. 2015;212(4):487.e1-487.e11.10.1016/j.ajog.2015.02.010445618425687564
  10. 10. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG. 2006;113(3):17-42.10.1111/j.1471-0528.2006.01120.x706229817206962
  11. 11. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103(3):551-6310.1097/01.AOG.0000114989.84822.5114990421
  12. 12. Krupa, FG, Faltin D, Cecatti JG, Surita FG, Souza, JP. Predictors of preterm birth. Int J Gynaecol Obstet. 2006;94(1):5-1110.1016/j.ijgo.2006.03.022
  13. 13. Jakobsson, M, Gissler M, Sainio, S, Paavonen J, Tapper AM. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol. 2007;109(2 Pt1):309-13.10.1097/01.AOG.0000253239.87040.23
  14. 14. Goldenberg RL, Davis RO, Cutter GR, Hoffman HJ, Brumfield CG, Foster JM. Prematurity, postdates, and growth retardation: the influence of use of ultrasonography on reported gestational age. Am J ObstetGynecol. 1989;160(2):462-70.10.1016/0002-9378(89)90473-0
  15. 15. Ambrose CS, Caspard H, Rizzo C, Stepka EC, Keenan G. Standard methods based on last menstrual period dates misclassify and overestimate US preterm births. J Perinatol. 2015;35(6):411-4.10.1038/jp.2015.25
  16. 16. Iams JD, Romero R, Culhane JF, Goldenberg RL. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet. 2008;371(9607):164-75.10.1016/S0140-6736(08)60108-7
  17. 17. Saurel-Cubizolles MJ, Zeitlin J, Lelong N, Papiernik E, Di Renzo GC Breart, G, et al. Employment, working conditions, and preterm birth: results from the Europop case-control survey. J Epidemiol Community Health. 2004;58(5):395-401.10.1136/jech.2003.008029
  18. 18. Behrman RE, Adashi EY, Allen MC, Caruso RL, Butler AS, Culhane J, et al. Preterm birth: causes, consequences, and prevention. Behrman RE, Butler AS, editors. Washington: National Academies Press; 2007.
  19. 19. Alwan NA, Roderick PJ, Macklon NS. Is timing of the first antenatal visit associated with adverse birth outcomes? Analysis from a population- based birth cohort. The Lancet. 2016;388: S18.10.1016/S0140-6736(16)32254-1
  20. 20. Stamilio DM, Chang JJ, Macones GA. Periodontal disease and preterm birth: do the data have enough teeth to recommend screening and preventive treatment? Am J Obstet Gynecol. 2007; 196(2):93-4.10.1016/j.ajog.2006.09.02917306643
  21. 21. Hosny AEMS, El-Khayat W, Kashef MT, Fakhry MN. Association between preterm labor and genitourinary tract infections caused by Trichomonas vaginalis, Mycoplasma hominis, Gram-negative bacilli, and coryneforms. J Chin Med Assoc. 2017;80(9):575-81.10.1016/j.jcma.2016.10.00728094234
  22. 22. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2015:8.10.1002/14651858.CD000490.pub326252501
  23. 23. Celik E, To M, Gajewska K, Smith GC, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet Gynecol. 2008;31(5):549-54.10.1002/uog.533318432605
  24. 24. Heath VC, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides KH. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. BJOG 2000;107(10):1276-81.10.1111/j.1471-0528.2000.tb11620.x11028581
  25. 25. Daskalakis GJ, Papantoniou NE, Koutsodimas NB, Papapanagiotou A, Antsaklis AJ. Fetal fibronectin as a predictor of preterm birth. J Obstet Gynaecol. 2000;20(4):347-53.10.1080/0144361005011192215512582
  26. 26. Son M, Miller ES. Predicting preterm birth: cervical length and fetal fibronectin. Semin Perinatol. 2017;41(8):445-51.10.1053/j.semperi.2017.08.002603351828935263
  27. 27. Kagan KO, To M, Tsoi E, Nicolaides KH. Preterm birth: the value of sonographic measurement of cervical length. BJOG. 2006;113(3):52-6.10.1111/j.1471-0528.2006.01124.x17206965
  28. 28. Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. Am J Obstet Gynecol. 2006;194(3):617-23.10.1016/j.ajog.2005.11.04916522388
  29. 29. Thinkhamrop J, Hofmeyr GJ, Adetoro O, Lumbiganon P, Ota E. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity. Cochrane Database Syst Rev. 2015;20;(6):CD002250.10.1002/14651858.CD002250.pub225621770
  30. 30. Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen, J. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol. 2011;117(3):663-71.10.1097/AOG.0b013e31820ca84721446209
  31. 31. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462-9.10.1056/NEJMoa06781517671254
  32. 32. Romero R, Nicolaides KH, Conde-Agudelo A, O’Brien JM, Cetingoz E, Da Fonseca E, et al. Vaginal progesterone decreases preterm birth :≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol. 2016;48(3):308-17.10.1002/uog.15953505323527444208
  33. 33. Romero R, Conde-Agudelo A, El-Refaie W, Rode L, Brizot ML, Cetingoz E, et al. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol. 2017;49(3):303-14.10.1002/uog.17397539628028067007
  34. 34. Houlihan C, Poon LC, Ciarlo M, Kim E, Guzman ER, Nicolaides KH. Cervical cerclage for preterm birth prevention in twin gestation with short cervix: a retrospective cohort study. Ultrasound Obstet Gynecol. 2016;48(6):752-6.10.1002/uog.1591826990136
  35. 35. Nicolaides KH, Syngelaki A, Poon LC, de Paco Matallana C, Plasencia W, Molina FS, et al. Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial. Am J ObstetGynecol. 2016;214(1):3.e1-9.10.1016/j.ajog.2015.08.05126321037
  36. 36. Dugoff L, Berghella V, Sehdev H, Mackeen AD, Goetzl L, Ludmir J. Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial. Ultrasound Obstet Gynecol 2018;51-5 №:573-9.10.1002/uog.1890828940481
  37. 37. van ‘t Hooft J, van der Lee JH, Opmeer BC, van Wassenaer-Leemhuis AG, van Baar AL, Bekedam DJ, et al. Pessary for prevention of preterm birth in twin pregnancy with short cervix: 3-year follow-up study. Ultrasound Obstet Gynecol. 2018; 51(5):621-8.10.1002/uog.1902929468770
  38. 38. Alfirevic Z, Allen-Coward H, Molina F, Vinuesa CP, Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial.Ultrasound Obstet Gynecol. 2007;29(1):47-50.10.1002/uog.390817201013
  39. 39. Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound ObstetGynecol. 2010;35(1):54-64.10.1002/uog.745720014326
  40. 40. Boots AB, Sanchez-Ramos L, Bowers DM, Kaunitz AM, Zamora J, Schlattmann P. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. Am J Obstet Gynecol. 2014;210(1):54.e1-54. e10.10.1016/j.ajog.2013.09.00424021995
  41. 41. Levine LD, Downes KL,, Romero JA, Pappas H, Elovitz MA. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study. J Matern Fetal Neonatal Med. 2018;15:1-9.
  42. 42. Todesco M, Hartog M, Fabbro T, Lapaire O, Hoesli IM.The combination of the fetal fibronectin bedside test and cervical length in preterm labor is useful for prediction of preterm birth. Open J Obstet Gynecol. 2015;5:746-53.10.4236/ojog.2015.513105
  43. 43. Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH. Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labour. Ultrasound Obstet Gynaecol. 2006;27(4):368-72.10.1002/uog.272316526097
  44. 44. A multicenter randomized controlled trial of home uterine monitoring: active versus sham device. The Collaborative Home Uterine Monitoring Study (CHUMS) Group. Am J Obstet Gynecol. 1995;173(4):1120-7.10.1016/0002-9378(95)91337-8
  45. 45. Wing DA, Haeri S, Silber AC, Roth CK, Weiner CP, Echebiri NC, et al. Placental alpha microglobulin-1 compared with fetal fibronectin to predict preterm delivery in symptomatic women. Obstet Gynecol. 2017;130(6):1183-91.10.1097/AOG.000000000000236729112664
  46. 46. Riboni F, Vitulo A, Dell’avanzo M, Plebani M, Battagliarin G, Paternoster D. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin. Arch Gynecol Obstet. 2011;284(6):1325-9.10.1007/s00404-011-1839-421274721
  47. 47. Liong S, Di Quinzio MK, Fleming G, Permezel M, Rice GE, Georgiou HM. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin. BJOG. 2015;122(3):370-9.10.1111/1471-0528.1299325056135
Language: English
Page range: 95 - 104
Submitted on: Jun 12, 2018
Accepted on: Jan 17, 2019
Published on: Dec 30, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2019 Ivan D. Ivanov, Stefan A. Buzalov, Nadezhda H. Hinkova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.